Foley Attorneys Publish on Telemedicine Considerations for Decentralized Clinical Trials
January 14, 2025
Applied Clinical Trials
Foley & Lardner LLP attorneys Jessica Warwick, Kyle Faget, and Monica Chmielewski authored the Applied Clinical Trials article, “Telemedicine Considerations When Conducting Decentralized Clinical Trials.”
“Decentralized clinical trials (DCTs) involve some or all trial-related activities conducted at locations other than traditional clinical trial sites, such as via telemedicine or in a clinical trial participant’s home,” the authors write. “The use of telemedicine in DCTs implicates various state legal and regulatory considerations as the performance of research, or the performance of certain procedures within a clinical trial, may and often fall within and are deemed to be the ‘practice of medicine.'”
Related News
June 18, 2026
In the News
Scott Ellis Weighs in on Texas Data Center Development
Foley & Lardner LLP partner Scott Ellis spoke to the Houston Chronicle about the growth of data centers in Texas.
June 12, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
June 10, 2026
In the News
Louis Lehot and Patrick Daugherty Publish on Revitalizing IPO Markets
Foley & Lardner LLP partners Louis Lehot and Patrick Daugherty authored the Westlaw Today article, How to Make IPOs Great Again, analyzing SEC public market reform proposals.